Die Paper zu diesem Podcast:

• Zur Dauer der Immunantwort:

Eric Laing et al, medRxiv, 2021 "SARS-CoV-2 antibodies remain detectable 12 months after infection and antibody magnitude is associated with age and COVID-19 severity"

• Antikörper-Antwort auf Infektion (Kölner Studie):

Kanika Vanshylla et al, Cell Host & Microbe, 2021, "Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans"

• Immun-T-Zell-Antwort nach Impfung:

Kathleen Gallagher et al, bioRxiv, 2021, "SARS-CoV-2 T-cell immunity to variants of concern following vaccination"

• Immunantwort bei Krebskranken:

Leticia Monin et al, Lancet Oncology, 2021 "Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study"